Does a Placebo Run-In or a Placebo Treatment Cell Affect the Efficacy of Antidepressant Medications?

@article{Trivedi1994DoesAP,
  title={Does a Placebo Run-In or a Placebo Treatment Cell Affect the Efficacy of Antidepressant Medications?},
  author={M. Trivedi and J. Rush},
  journal={Neuropsychopharmacology},
  year={1994},
  volume={11},
  pages={33-43}
}
  • M. Trivedi, J. Rush
  • Published 1994
  • Medicine
  • Neuropsychopharmacology
  • During the last decade, there has been an increasing use of a placebo run-in period prior to randomization to active treatments, or placebo in randomized controlled trials aimed at establishing acute phase antidepressant drug efficacy in patients with major depression. This procedure is thought to reduce response rates to placebo treatment after randomization, thereby increasing the drug-placebo difference. Metaanalyses of 101 studies reveal that a placebo run-in does not (1) lower the placebo… CONTINUE READING

    Tables and Topics from this paper.

    Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.
    • 573
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 98 REFERENCES
    A RATING SCALE FOR DEPRESSION
    • 25,615
    • Highly Influential
    • PDF
    National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments.
    • 2,115
    • PDF
    A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder.
    • 237
    Antidepressant specificity in atypical depression.
    • 296
    Imipramine and chlordiazepoxide in depressive and anxiety disorders. I. Efficacy in depressed outpatients.
    • 199
    A multiple-dose, controlled study of phenelzine in depression-anxiety states.
    • 110